Through clonogenic survival assays, we found that curcumin increased the sensitivity of Capan1 cells to CPT-11 (Figure 5F), which is consistent with previous results that curcumin sensitizes BRCA2-deficient cancer cells to DNA damaging drugs (Figure 3). This evidence concerns the gene BRCA2 and cancer.